|
Hamps Bio Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
22.22 Cr.
|
P/BV
|
2.74
|
Book Value (Rs.)
|
9.30
|
|
52 Week High/Low (Rs.)
|
30/13
|
FV/ML
|
10/4000
|
P/E(X)
|
0.00
|
|
Bookclosure
|
09/09/2025
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | PR |
| FaceValue | 10.00 | 10.00 |
| | | |
| PER SHARE RATIOS | | |
| | | |
| Basic EPS (Rs.) | -0.85 | 0.68 |
| Diluted EPS (Rs.) | -0.85 | 0.68 |
| Cash EPS (Rs.) | 0.08 | 1.55 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.30 | 20.20 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.30 | 20.20 |
| Revenue From Operations / Share (Rs.) | 9.73 | 15.31 |
| PBDIT / Share (Rs.) | 0.41 | 2.11 |
| PBIT / Share (Rs.) | -0.51 | 1.25 |
| PBT / Share (Rs.) | -0.80 | 0.92 |
| Net Profit / Share (Rs.) | -0.84 | 0.68 |
| NP After MI And SOA / Share (Rs.) | -0.84 | 0.68 |
| | | |
| PROFITABILITY RATIOS | | |
| | | |
| PBDIT Margin (%) | 4.31 | 13.80 |
| PBIT Margin (%) | -5.32 | 8.14 |
| PBT Margin (%) | -8.25 | 6.05 |
| Net Profit Margin (%) | -8.71 | 4.46 |
| NP After MI And SOA Margin (%) | -8.71 | 4.46 |
| Return on Networth / Equity (%) | -9.11 | 3.38 |
| Return on Capital Employeed (%) | -3.66 | 4.97 |
| Return On Assets (%) | -4.64 | 2.32 |
| Long Term Debt / Equity (X) | 0.50 | 0.23 |
| Total Debt / Equity (X) | 0.84 | 0.33 |
| | | |
| LIQUIDITY RATIOS | | |
| | | |
| Current Ratio (X) | 1.46 | 2.26 |
| Quick Ratio (X) | 0.75 | 0.99 |
| | | |
| COVERAGE RATIOS | | |
| | | |
| Interest Coverage Ratio (%) | 1.47 | 6.60 |
| Interest Coverage Ratio (Post Tax) (%) | -1.97 | 3.13 |
| | | |
| VALUATION RATIOS | | |
| | | |
| Enterprise Value (Cr.) | 21.13 | 21.49 |
| EV / Net Operating Revenue (X) | 2.49 | 3.22 |
| EV / EBITDA (X) | 57.80 | 23.35 |
| MarketCap / Net Operating Revenue (X) | 1.70 | 2.79 |
| Price / BV (X) | 1.78 | 2.12 |
| Price / Net Operating Revenue (X) | 1.70 | 2.79 |
| EarningsYield | -0.05 | 0.01 |
